Welcome to BioLegend’s one-of-a-kind advanced search. Search by any one of the single fields below or narrow down your searches by using multiple parameters. Looking for an anti-mouse NK cell antibody for IHC? Or looking for a FITC-conjugated antibody against a human marker for dendritic cells to use for flow cytometry? Only BioLegend’s advanced search can provide you with the best answers. If you have further questions, please contact our technical service team at 858-768-5801.
Use this document lookup tool to find Current Product Datasheets, Certificates of Analysis, or MSDS for any antibody products you have purchased from BioLegend.
Use the search box below to perform a site search of BioLegend.com powered by Google™.
The antibody was purified by affinity chromatography and conjugated with Brilliant Violet 605™ under optimal conditions. The solution is free of unconjugated Brilliant Violet 605™ and unconjugated antibody.
Storage & Handling:
The antibody solution should be stored undiluted at 4°C and protected from prolonged exposure to light. Do not freeze.
Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For immunofluorescent staining, the suggested use of this reagent is ≤5 µl per million cells or 5 µl per 100 µl of whole blood. It is recommended that the reagent be titrated for optimal performance for each application.
Brilliant Violet 605™ excites at 405 nm and emits at 603 nm. The bandpass filter 610/20 nm is recommended for detection, although filter optimization may be required depending on other fluorophores used. Be sure to verify that your cytometer configuration and software setup are appropriate for detecting this channel. Refer to your instrument manual or manufacturer for support. Brilliant Violet 605™ is a trademark of Sirigen Group Ltd.
Additional reported applications (for relevant formats of this clone) include: inhibition of CD45 functions2, and immunohistochemical staining of frozen tissue sections3 and formalin-fixed paraffin-embedded tissue sections4.
Application References:
1. Knapp W, et al. 1989. Leucocyte Typing IV. Oxford University Press. New York. 2. Yamada T, et al. 2002. J. Biol. Chem. 277:28830. (WB, Block) 3. Weninger W, et al. 2003 J. Immunol. 170:4638. (IHC) 4. Imanguli MM, et al. 2009. Blood. 113:3620 (IHC) 5. Roque S, et al. 2007. J. Immunol. 178:8028. (FC) PubMed 6. Smeltz RB. 2007. J. Immunol. 178:4786. (FC) PubMed 7. Palendira U, et al. 2008. Blood (FC)PubMed 8. Kuttruff S, et al. 2009. Blood 113:358. (FC) PubMed 10. Thakral D, et al. 2008. J. Immunol. 180:7431. (FC) PubMed 11. Alanio C, et al. 2010. Blood 115:3718. (FC) PubMed 12. Iannello A, et al. 2010. J. Immunol. 184:114. (FC) PubMed 13. Yoshino N, et al. 2000. Exp. Anim. (Tokyo) 49:97. (FC) 14. Guereau-de-Arellan M, et al. 2011. Brain. PubMed.
Human peripheral blood lymphocytes were stained with CD45RO FITC and CD45RA (clone HI100) Brilliant Violet 605™.
CD45RA is a 205-220 kD single chain type I glycoprotein. It is an exon 4 splice variant of the tyrosine phosphatase CD45. The CD45RA isoform is expressed on resting/naive T cells, medullary thymocytes, B cells and monocytes. CD45RA enhances both T cell receptor and B cell receptor signaling. CD45 non-covalently associates with lymphocyte phosphatase-associated phosphoprotein (LPAP) on T and B lymphocytes. CD45 has been reported to be associated with several other cell surface antigens including CD1, CD2, CD3, and CD4. CD45 has also been reported to bind galectin-1. CD45 isoform expression can change in response to cytokines.
Structure:
Tyrosine phosphatases, type I transmembrane (exon 4 splicing of CD45 gene), 205-220 kD
Distribution:
B cells, naïve T cells, monocytes
Function:
Enhances TCR and BCR signaling
Ligand Receptor:
Galectin-1, CD2, CD3, CD4
Antigen References:
1. Thomas M. 1989. Annu. Rev. Immunol. 7:339. 2. Trowbridge I, et al. 1994. Annu. Rev. Immunol.12:85.
*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/terms). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.
This data display is provided for general comparisons between formats. Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors. If you need assistance with selecting the best format contact our expert technical support team.
APC anti-human CD45RA
Human peripheral blood lymphocytes stained with HI100 APC
Biotin anti-human CD45RA
Human peripheral blood lymphocytes stained with biotinylated HI100,followed by Sav-PE
FITC anti-human CD45RA
Human peripheral blood lymphocytes stained
with HI100 FITC
PE anti-human CD45RA
Human peripheral blood lymphocytes were stained with CD45RA (clone HI100) PE (filled histogram) or mouse IgG2b, κ PE isotype control (open histogram).
PE/Cy5 anti-human CD45RA
Human peripheral blood lymphocytes stained with HI100 PE/Cy5
Purified anti-human CD45RA
Human peripheral blood platelets stained with purified HI100, followed by anti-mouse IgGs FITC
Alexa Fluor® 488 anti-human CD45RA
Human peripheral blood lymphocytes stained with HI100 Alexa Fluor® 488
Pacific Blue™ anti-human CD45RA
Human peripheral blood lymphocytes stained with HI100 Pacific Blue™
Alexa Fluor® 700 anti-human CD45RA
Human peripheral blood lymphocytes stained with HI100 Alexa Fluor® 700
PerCP/Cy5.5 anti-human CD45RA
Human peripheral blood lymphocytes stained with HI100 PerCP/Cy5.5
PE/Cy7 anti-human CD45RA
Human peripheral blood lymphocytes were stained with HI100 PE/Cy7 (filled histogram) or mouse IgG2b, κ PE/Cy7 isotype control (open histogram).
APC/Cy7 anti-human CD45RA
Human peripheral blood lymphocytes were stained CD45RA (clone HI100) APC/Cy7 (filled histogram) or mouse IgG2b, κ APC/Cy7 isotype control (open histogram).
Brilliant Violet 421™ anti-human CD45RA
Human peripheral blood lymphocytes were stained with CD45RO FITC and CD45RA (clone HI100) Brilliant Violet 421™ (top) or mouse IgG2b, κ Brilliant Violet 421™ isotype control (bottom).
Brilliant Violet 570™ anti-human CD45RA
Human peripheral blood lymphocytes were stained with CD45RO FITC and CD45RA (clone HI100) Brilliant Violet 570™ (top) or mouse IgG2b, κ Brilliant Violet 570™ isotype control (bottom).
Brilliant Violet 605™ anti-human CD45RA
Human peripheral blood lymphocytes were stained with CD45RO FITC and CD45RA (clone HI100) Brilliant Violet 605™.
Brilliant Violet 650™ anti-human CD45RA
Human peripheral blood lymphocytes were stained with CD45RO FITC and CD45RA (clone HI100) Brilliant Violet 650™.
